Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
Italy
· Delayed Price · Currency is EUR 48.78
-0.10 (-0.20%)
At close: Dec 5, 2025
Recordati Industria Chimica e Farmaceutica Employees
As of December 31, 2024, Recordati Industria Chimica e Farmaceutica had 4,583 total employees, including 4,495 full-time and 88 part-time employees. The number of employees increased by 128 or 2.87% compared to the previous year.
Employees
4,583
Change (1Y)
128
Growth (1Y)
2.87%
Revenue / Employee
€562,820
Profits / Employee
€89,093
Market Cap
9.98B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| DiaSorin | 3,308 |
| Amplifon | 15,070 |
| EL.En. | 2,080 |
| Philogen | 183 |
| Safilo Group | 3,645 |
| Pharmanutra | 118 |
| Garofalo Health Care | 2,708 |
| GPI S.p.A. | 7,656 |
Recordati Industria Chimica e Farmaceutica News
- 10 days ago - Recordati SpA (RICFY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - GuruFocus
- 23 days ago - Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Amarin outlines accelerated path to positive free cash flow in 2026 supported by Recordati partnership and $70M OpEx savings - Seeking Alpha
- 4 months ago - Amarin targets $70M cost savings and accelerates VAZKEPA European expansion through Recordati partnership - Seeking Alpha
- 4 months ago - Italy's Recordati CEO sees rare disease drugs exempt from U.S. tariffs - Reuters
- 4 months ago - Five years after COVID, pharma shares languish in US policy limbo - Reuters
- 5 months ago - Amarin Shares Surge After $175M European Licensing Deal For Heart Drug VAZKEPA - Benzinga
- 5 months ago - Amarin Lands Massive European Commercialization Deal For Heart Drug Vazkepa, Stock Surges - Benzinga